- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
4005
SAU
Week ended 07 Aug 2026
Weekly Investor Report
National Medical Care Company · Healthcare · Medical Care Facilities
Latest close
125.2 SAR
10.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 2.8% above the Trend Line and sits at 36.1% of its 52-week range. The latest completed week returned 10.8%, after a 10.2% four-week move. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.
Setup score
42
out of 100
Latest Close
125.2 SAR
7 Aug 2026
1W Return
10.8%
latest completed week
4W Return
10.2%
short-term follow-through
12W Return
27.5%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
10.8%
Latest completed week; four-week move 10.2%.
Indicator stack
14/85
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Buy
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 2.8% above the Trend Line and sits at 36.1% of its 52-week range. The latest completed week returned 10.8%, after a 10.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1112-week average 0.05
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.11Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 10.2% over four weeks, 27.5% over 12 weeks, and -25.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.65Latest activity-pressure read.
Pressure change294.0%Four-week change in activity pressure.
Leadership-7.84Latest relative-leadership reading.
RS change56.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 11 relevant articles.
1 positive · 10 neutral · 0 negativePatient CapitalFresh
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-30.0%Distance below the 52-week high.
13-week volatility6.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2614 weeks finished lower.
Best week+10.8%Week of 7 Aug.
Worst week-18.8%Week of 20 Feb.
Latest week+10.8%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains5
Flat weeks1
Modest losses9
Sharp losses5
Recent vol6.8%13-week weekly-return volatility.
Base vol5.5%52-week weekly-return volatility.
Up/down split23/28Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSA Healthcare
4-week rank4 / 31
Group average0.0%
Trend breadth22.6%
Trend22.6%active weekly trend signals
MD29.0%positive activity pressure
RS19.4%positive relative leadership
Four-week leaders
IndustrySA Medical Care Facilities
4-week rank4 / 17
Group average1.7%
Trend breadth23.5%
Trend23.5%active weekly trend signals
MD29.4%positive activity pressure
RS17.6%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape34/100
Trend, activity pressure, participation, and risk combine to a 34/100 tape read.
Indicator analysis16/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.11; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalFreshActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal Sentiment53/100Weighted news tone is neutral across 11 relevant articles.
Did Earnings Turnaround and Higher Dividends Just Shift Sumitomo Chemical's (TSE:4005) Investment Narrative? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 125.2 SAR | 10.8% | 121.7 SAR | 154.5 SAR | 0.65 | -7.84 | 625.6K | Off |
| 31 Jul 2026 | 113.0 SAR | -1.7% | 122.3 SAR | 154.6 SAR | 0.42 | -15.23 | 403.4K | Off |
| 24 Jul 2026 | 115.0 SAR | 5.3% | 123.2 SAR | 154.7 SAR | 0.11 | -15.94 | 891.1K | Off |
| 17 Jul 2026 | 109.2 SAR | -3.9% | 124.0 SAR | 154.7 SAR | -0.24 | -20.21 | 461.0K | Off |
| 10 Jul 2026 | 113.6 SAR | 8.1% | 124.8 SAR | 154.8 SAR | -0.34 | -18.20 | 632.5K | Off |
| 3 Jul 2026 | 105.1 SAR | -0.1% | 125.7 SAR | 154.9 SAR | -0.59 | -24.88 | 289.4K | Off |
| 26 Jun 2026 | 105.2 SAR | -3.5% | 126.8 SAR | 155.0 SAR | -0.56 | -26.06 | 576.5K | Off |
| 19 Jun 2026 | 109.0 SAR | 7.9% | 128.1 SAR | 154.9 SAR | -0.71 | -25.16 | 2.0M | Off |
| 12 Jun 2026 | 101.0 SAR | -4.8% | 129.4 SAR | 154.9 SAR | -0.97 | -30.65 | 968.6K | Off |
| 5 Jun 2026 | 106.1 SAR | 8.1% | 131.1 SAR | 154.9 SAR | -1.03 | -27.38 | 1.7M | Off |
| 29 May 2026 | 98.15 SAR | 0.0% | 132.7 SAR | 154.9 SAR | -1.18 | -33.53 | 0 | Off |
| 22 May 2026 | 98.15 SAR | -0.1% | 135.2 SAR | 154.8 SAR | -1.19 | -33.53 | 1.1M | Off |
| 15 May 2026 | 98.20 SAR | -15.1% | 137.5 SAR | 154.8 SAR | -1.11 | -33.81 | 1.6M | Off |
| 8 May 2026 | 115.6 SAR | -0.2% | 139.9 SAR | 154.7 SAR | -0.91 | -22.88 | 847.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.